Xu, Bo
Tian, Lei
Chen, Jing
Wang, Jing
Ma, Rui
Dong, Wenjuan
Li, Aimin
Zhang, Jianying
Antonio Chiocca, E. http://orcid.org/0000-0001-5183-1670
Kaur, Balveen http://orcid.org/0000-0001-7738-0804
Feng, Mingye
Caligiuri, Michael A.
Yu, Jianhua http://orcid.org/0000-0002-0326-3223
Funding for this research was provided by:
V Foundation for Cancer Research
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA068458, CA163205-01, CA201075, CA247550, CA223400)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS106170)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI129582)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Leukemia and Lymphoma Society (6503-17, 1364-19)
Leukemia and Lymphoma Society
California Institute for Regenerative Medicine (DISC2COVID19-11947)
2021 Exceptional Project Grants from The Breast Cancer Alliance
Article History
Received: 18 September 2020
Accepted: 9 September 2021
First Online: 8 October 2021
Competing interests
: J.Y. and M.A.C. are co-founders of CytoImmune, Inc. The remaining authors declare no competing interests.